Long-term tolerability, metabolic adaptation, and distant safety outcomes such as oncologic endpoints remain insufficiently characterized, and real-world challenges related to dose escalation, adherence, and rapid weight loss-associated risks (e.g., muscle loss, nutritional imbalance) may be more pronounced than in clinical trials
Here are my current insights based on my experience with it
If youre considering GLP-1 medications, there are several great providers focused on helping women in menopause
Gentle exfoliation removes dead skin cells and improves clarity without irritation
Theyll then close your incision with sutures (stitches)
The most commonly prescribed GLP-1 RAs are: Semaglutide: Ozempic (type 2 diabetes), Wegovy (weight loss) Tirzepatide: Mounjaro (type 2 diabetes), Zepbound (weight loss) Dulaglutide: Trulicity (type 2 diabetes) Liraglutide: Victoza (type 2 diabetes), Saxenda (weight loss) According to the Endocrine Society, GLP-1 RAs promote early satiety, reduce food intake, and are associated with weight loss ( Endocr Pract , 2022)
